YSXT vs NAMI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 06, 2026
YSXT
NAMI
Investment Advisor Scores
NAMI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | YSXT | NAMI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 13.7% | -31.9% | YSXT |
| Earnings Growth | -95.1% | 0.0% | NAMI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.4/100 | 53.3/100 | NAMI |
| Profit Margin | 3.4% | -23.9% | YSXT |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | BUY | NAMI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
YSXT
MarkupPrice above SMA50, rising 50-day trend (12.4% over 20 days), RSI 54
NAMI
MarkdownPrice below a falling SMA50 (slope -18.1%), weak momentum, RSI 40
Fundamentals Snapshot
| Metric | YSXT | NAMI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 0.0 |
| Trailing P/E | 12.5 | 0.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.3% |
| Gross Margin | 0.1% | 0.1% |
| Operating Margin | 0.0% | -0.1% |
| EPS | 0.11 | 1.93 |
| Dividend Yield | — | — |